Cargando…

EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody

BACKGROUND: The availability of a reliable tumor target for advanced colorectal cancer (CRC) therapeutic approaches is critical since current treatments are limited. Epidermal growth factor-like domain 6 (EGFL6) has been reported to be associated with cancer development. Here, we focused on the role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Ting-Yi, Huang, Han-Li, Cheng, Chun-Chun, Chang, Fu-Ling, Wei, Po-Li, Cheng, Ya-Wen, Huang, Cheng-Chiao, Lee, Yu-Ching, HuangFu, Wei-Chun, Pan, Shiow-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962215/ https://www.ncbi.nlm.nih.gov/pubmed/33726836 http://dx.doi.org/10.1186/s13578-021-00561-0

Ejemplares similares

The polymorphism of EGFL6 D535N is not associated with obesity in Chinese children
por: Wang, Chun Lin, et al.
Publicado: (2013)

Thalidomide targets EGFL6 to inhibit EGFL6/PAX6 axis-driven angiogenesis in small bowel vascular malformation
por: Tang, Chao-Tao, et al.
Publicado: (2020)

The emerging role of EGFL6 in angiogenesis and tumor progression
por: Kang, Jing, et al.
Publicado: (2020)

High Level of Plasma EGFL6 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma
por: Chuang, Chun-Yi, et al.
Publicado: (2017)

Osteoblast-derived EGFL6 couples angiogenesis to osteogenesis during bone repair
por: Chen, Kai, et al.
Publicado: (2021)

egfl6 expression in the pharyngeal pouch is dispensable for craniofacial development
por: Jin, Sil, et al.
Publicado: (2021)

LncEGFL7OS regulates human angiogenesis by interacting with MAX at the EGFL7/miR-126 locus
por: Zhou, Qinbo, et al.
Publicado: (2019)

Formin‐like 2 promotes angiogenesis and metastasis of colorectal cancer by regulating the EGFL6/CKAP4/ERK axis
por: He, Guoyang, et al.
Publicado: (2023)

The Multifaceted Roles of EGFL7 in Cancer and Drug Resistance
por: Heissig, Beate, et al.
Publicado: (2021)

Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study
por: Chang, Chun-Chi, et al.
Publicado: (2018)

Novel Expression of EGFL7 in Osteosarcoma and Sensitivity to Cisplatin
por: Liu, Qing, et al.
Publicado: (2020)

EGFL7 reduces CNS inflammation in mouse
por: Larochelle, Catherine, et al.
Publicado: (2018)

Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer
por: Zhu, Wenhui, et al.
Publicado: (2020)

Egfl7 promotes tumor escape from immunity
por: Pinte, Sébastien, et al.
Publicado: (2012)

The Polymorphism and Expression of EGFL7 and miR-126 Are Associated With NSCLC Susceptibility
por: Liu, Weipeng, et al.
Publicado: (2022)

miR-6086 inhibits ovarian cancer angiogenesis by downregulating the OC2/VEGFA/EGFL6 axis
por: Wu, Binhua, et al.
Publicado: (2020)

Elevated EGFL6 modulates cell metastasis and growth via AKT pathway in nasopharyngeal carcinoma
por: Zhu, Ziyu, et al.
Publicado: (2018)

EGFL6 regulates angiogenesis and osteogenesis in distraction osteogenesis via Wnt/β-catenin signaling
por: Shen, Junjie, et al.
Publicado: (2021)

Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First‐Line Metastatic Colorectal Cancer
por: García‐Carbonero, Rocío, et al.
Publicado: (2017)

EGFL7 meets miRNA-126: an angiogenesis alliance
por: Nikolic, Iva, et al.
Publicado: (2010)

Effect and Mechanism of EGFL7 Downregulation in Human Osteosarcoma Cells on the Biological Function of Co-cultured HUVEC
por: Li, Xia, et al.
Publicado: (2018)

Low EGFL7 expression is associated with high lymph node spread and invasion of lymphatic vessels in colorectal cancer
por: de Oliveira, Cristiane, et al.
Publicado: (2023)

EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogramming
por: Meng, Fanyan, et al.
Publicado: (2019)

Paeoniflorin Inhibits the Proliferation and Metastasis of Ulcerative Colitis-Associated Colon Cancer by Targeting EGFL7
por: Wang, Yunxia, et al.
Publicado: (2022)

EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling
por: Wang, Yubo, et al.
Publicado: (2022)

Identification of a Peptide from In vivo Bacteriophage Display with Homology to EGFL6: A Candidate Tumor Vasculature Ligand in Breast Cancer
por: Larimer, Benjamin M, et al.
Publicado: (2014)

A Distinct Mechanism of Vascular Lumen Formation in Xenopus Requires EGFL7
por: Charpentier, Marta S., et al.
Publicado: (2015)

Egfl7 Is Differentially Expressed in Arteries and Veins during Retinal Vascular Development
por: Poissonnier, Loïc, et al.
Publicado: (2014)

Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling
por: Kao, Der-I, et al.
Publicado: (2015)

Analysis of Gene Expression Profiling in Meningioma: Deregulated Signaling Pathways Associated with Meningioma and EGFL6 Overexpression in Benign Meningioma Tissue and Serum
por: Wang, Xuanchun, et al.
Publicado: (2012)

A role for Egfl7 during endothelial organization in the embryoid body model system
por: Durrans, Anna, et al.
Publicado: (2010)

Circulating EGFL7 distinguishes between IUGR and PE: an observational case–control study
por: Massimiani, Micol, et al.
Publicado: (2021)

EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome
por: da Costa, Bruno Henrique Bressan, et al.
Publicado: (2022)

Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway
por: Wu, Fan, et al.
Publicado: (2021)

Neurovascular EGFL7 regulates adult neurogenesis in the subventricular zone and thereby affects olfactory perception
por: Bicker, Frank, et al.
Publicado: (2017)

High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer
por: Pannier, Diane, et al.
Publicado: (2016)

Transcriptome Analyses of Adipose Tissue Samples Identify EGFL6 as a Candidate Gene Involved in Obesity-Related Adipose Tissue Dysfunction in Children
por: Landgraf, Kathrin, et al.
Publicado: (2022)

Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non‐Small Cell Lung Cancer
por: von Pawel, Joachim, et al.
Publicado: (2018)

Transcriptional regulation of blood vessel formation: The role of the CASZ1/Egfl7/RhoA pathway
por: Charpentier, Marta S, et al.
Publicado: (2013)

Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury
por: Lin, Chao-Feng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n3thsfv36ktl8d3qaroufo3lm7